Prognostic utility of systemic immune-inflammation markers in locally advanced cervical cancer undergoing radical radiotherapy [0.03%]
系统免疫炎症标志物在广泛期宫颈癌根治性放疗中的预后价值
Yue Li,Jing Han,Shuyue Xiao et al.
Yue Li et al.
Purpose: To improve survival prediction in locally advanced cervical cancer (LACC) post-radiotherapy, we developed and compared a nomogram and machine learning (ML) models using immune-inflammatory markers. ...
The efficacy of sequential radiotherapy after the combination of TACE with lenvatinib and anti-PD-1 antibodies for unresectable HCC [0.03%]
经肝动脉化疗栓塞联合仑伐替尼和抗PD-1抗体治疗后的序贯放疗对不可切除的肝细胞癌疗效分析
Xiangye Ou,Jinhai Li,Rongjian Pan et al.
Xiangye Ou et al.
Background: Triple therapy of transcatheter arterial chemoembolization (TACE) combined with lenvatinib and anti-PD-1 antibodies has demonstrated excellent efficacy in unresectable hepatocellular carcinoma (uHCC). However,...
Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLC [0.03%]
基于液体活检的获得性MET耐药检测指导MET融合阳性NSCLC序贯靶向治疗
Stanislav Rosnev,Katharina Klein,Lukas Heukamp et al.
Stanislav Rosnev et al.
Oncogenic alterations in MET represent therapeutically actionable driver alterations in non-small cell lung cancers (NSCLC). Among these, MET fusions are rare, occurring in approximately 0.1-0.3% of NSCLC. We report the case of a 52-year-ol...
Long-term outcome of isolated locoregional breast cancer recurrence: a large retrospective mono-institutional study [0.03%]
孤立局部区域乳腺癌复发的长期预后：一项单中心回顾性大样本研究
Grazia Vernaci,Gaia Griguolo,Fabio Girardi et al.
Grazia Vernaci et al.
Background: Isolated locoregional relapse (ILRR) after curative treatment for early breast cancer (BC) is associated with poor prognosis. Treatment strategies are poorly standardized. We aimed at exploring prognostic fact...
Trajectories of health care contact days experienced by decedents who underwent curative-intent surgery for pancreatic cancer [0.03%]
接受治愈性胰腺癌手术的死者生前就医接触时间轨迹分析
Whitney V Johnson,Khalid Ishani,Amy A Gravely et al.
Whitney V Johnson et al.
Patients with pancreatic cancer undergoing curative-intent surgery face incredible burdens, even long-term after surgery, but the amount of time spent in health care (ie, as health care contact days) was not hitherto quantified. In this coh...
Next generation sequencing identifies novel gene alterations with potential prognostic relevance in pediatric cancer: a single-center study [0.03%]
下一代测序鉴定出具有潜在预后价值的儿童肿瘤新型基因改变：一项单中心研究
Yuhan Ma,Mingwei Su,Xiaoshan Liu et al.
Yuhan Ma et al.
Background: Next generation sequencing (NGS) has driven the development of precision oncology. While adult cancer genomics has been extensively studied, pediatric cancer, particularly among Asian populations, has received...
Trends in Primary Surgery and Overall Survival in Non-Metastatic Anal Cancer: A Population-Based Analysis [0.03%]
非转移性直肠癌一期手术及总体生存率的流行病学研究：基于人口的分析结果
Chan Shen,Madison Conces,Kristen Ciombor et al.
Chan Shen et al.
Background: Anal cancer incidence is rising in the United States, now exceeding 10,000 cases annually. Chemoradiation (CRT) is the standard curative-intent treatment for non-metastatic squamous cell carcinoma of the anus ...
Gregory Goldmacher
Gregory Goldmacher
Matching-adjusted indirect comparisons of PARP inhibitor combinations in metastatic castration-resistant prostate cancer across key populations [0.03%]
在关键人群中匹配调整间接比较转移性去势抵抗性前列腺癌PARP抑制剂组合疗法的效果
Elena Castro,Di Wang,Stefanie Paganelli et al.
Elena Castro et al.
Background: Without head-to-head trials comparing talazoparib plus enzalutamide (TALA+ENZA), olaparib plus abiraterone acetate and prednisone (OLAP+AAP), and niraparib plus abiraterone acetate and prednisone (NIRA+AAP) as...
Comparative Study
The oncologist. 2026 Apr 10;31(5):oyag143. DOI:10.1093/oncolo/oyag143 2026
Health system strengthening recommendations for lung cancer care: lessons from the COVID-19 pandemic [0.03%]
新冠肺炎疫情对肺癌诊疗的启示：加强卫生系统建设的建议
Elysse Bautista-González,Mercedes Aguerrebere,Anne Peasey et al.
Elysse Bautista-González et al.
We explore how the COVID-19 pandemic amplified barriers across the lung cancer care continuum in Mexico. Drawing from a cross-sectional qualitative arm of a mixed-methods study (N = 46), interviews were conducted with lung cancer patients a...